FDA grants Fast Track designation to nintedanib for SSc-ILD
Boehringer Ingelheim has announced that the FDA has granted Fast…
Boehringer Ingelheim has announced that the FDA has granted Fast Track designation to nintedanib for the treatment of SSc-ILD...